NCT06813937 Peripheral Magnetic Stimulation (PMS) Effects on Somatosensory Perception in Patients with Upper Limb Amputation
| NCT ID | NCT06813937 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Skolkovo Institute of Science and Technology |
| Condition | Phantom Limb Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-09-16 |
| Primary Completion | 2027-09-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-09-16 with a primary completion date of 2027-09-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study investigates the capabilities of peripheral magnetic stimulation (PMS) as a tool for creating somatosensory sensations of various submodalities and analyzing the dynamics of bioelectric signals of the brain (using encephalography (EEG)) in healthy participants and participants with upper limb amputations. During the experiment, the participants' subjective sensations and EEG activity are recorded in response to magnetic pulses of varying intensity. In addition, the continuous PMS stimulation protocol and its effect on phantom sensations in participants with amputations will be tested for subsequent implementation in clinical practice.
Eligibility Criteria
For Healthy Volunteers: Inclusion Criteria: 1. Availability of signed written informed consent. 2. Absence of somatic and psychiatric diseases (more details in the exclusion criteria) 3. Ability and willingness to comply with the requirements of this protocol. Inclusion Criteria Exclusion Criteria: 1. History of epilepsy (participant, participant's close relatives) 2. Presence of metal or/and electric stimulators and/or implants in participant's body 3. Presence of psychiatric disorders (including a history of), severe depression, suicidal tendencies, or a history of suicide attempts. 4. History of cancer. 5. Complicated traumatic brain injury (TBI) or a history of stroke. 6. Drug addiction (including a history of). 7. Congenital anomaly of upper limb development. 8. Anomalies in the development of the central and peripheral nervous systems. 9. Pregnancy For stroke patients: 1. History of epilepsy (participant, participant's close relatives) 2. Presence of metal or/and electric stimulators and/or implants in participant's body 3. Presence of psychiatric disorders (including a history of), severe depression, suicidal tendencies, or a history of suicide attempts. 4. History of cancer. 5. Complicated traumatic brain injury (TBI) or a history of stroke. 6. Drug addiction (including a history of). 7. Congenital anomaly of upper limb development. 8. Anomalies in the development of the central and peripheral nervous systems. 9. Pregnancy 10. Presence of severe somatic pathology 11. Presence of severe orthopedic deformity in the limb above the level of amputation. 12. Purulent-septic pathology.
Frequently Asked Questions
Who can join the NCT06813937 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Phantom Limb Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06813937 currently recruiting?
Yes, NCT06813937 is actively recruiting participants. Visit ClinicalTrials.gov or contact Skolkovo Institute of Science and Technology to inquire about joining.
Where is the NCT06813937 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT06813937 clinical trial?
NCT06813937 is sponsored by Skolkovo Institute of Science and Technology. The trial plans to enroll 30 participants.